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1. Introduction 
During protein synthesis in cell-free extracts of 
Escherichia coli peptidyl-tRNA is located on one of 
two ribosomal binding sites [ 1 ] . The nascent peptide 
is transfered from tRNA bound at the P site on to 
amino acyl-tRNA bound at an adjacent A site [2]. 
This reaction requires an enzyme, peptidyl transferase, 
which is an integral part of the 50 S subunit [3] . 
Before the peptide chain can elongate further, pep- 
tidyl-tRNA bound at site A must be translocated to 
site P to allow a further amino acyl-tRNA to attach 
at site A. Translocation requires GTP hydrolysis and 
‘G’ factor [4]. 
Puromycin reacts with peptidyl-tRNA bound to 
site P to release peptidyl-puromycin [S, 61 . This 
reaction requires only the correct ionic environment 
and is catalysed by peptidyl transferase [7]. The puro- 
mycin reaction can thus be used to study the forma- 
tion of an individual peptide bond. Translocation can 
also be detected using puromycin since more peptide 
moves to site P. Finally, the reaction assays the distri- 
bution of peptidyl-tRNA between sites A and P in a 
given ribosome population. 
We have utilised the puromycin reaction to eluci- 
date the mechanisms of action of two antibiotics - 
thiostrepton and elythromycin. Both have been pro- 
posed to inhibit translocation [8,9] . Studies on 
washed ribosomes have suggested that thiostrepton, 
but not erythromycin, may inhibit translocation. After 
inhibition, by thiostrepton or erythromycin, of crude 
extracts actively synthesising protein, thiostrepton 
causes peptidyl-tRNA to accumulate in site P. Ery- 
thromycin apparently causes peptidyl-tRNA to ac- 
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cumulate in site A. We suggest hat thiostrepton may 
act primarily by blocking the binding of amino acyl- 
tRNA to ribosomes. Erythromycin may inhibit trans- 
location, but the possibility is not excluded that it 
could inhibi I the enzyme peptidyl transferase. 
2. Materials and methods 
E. coli strain B163 was grown, harvested and 
frozen until use [lo] . Crude extracts were prepared 
[l l] and diluted to 10 mg/ml ribosomes. 
Ribosome-free supernatant fraction was obtained 
from crude extracts [ 1 l] , and was dialysed for 18 hr 
at O-4” against 5 mM Tris-Cl buffer, pH 7.4, con- 
taining 10 mM magnesium acetate, 86 mM KC1 and 6 
mM mercaptoethanol, and stored frozen. 
The reaction mixture for amino acid incorporation 
into protein has been described [ 1 l] . Incubations 
were at 30’ for 5 min. Incorporations were directed 
by the natural messenger RNA of the extract. 
The puromycin reaction was with ribosomes pre- 
pared by centrifugation of incorporation mixtures at 
165,000 g for 45 min after dilution with 5 mM Tris- 
Cl buffer, pH 7.4, containing 10 mM magnesium 
acetate. Ribosome pellets were resuspended, to a con- 
centration of 2 mg/ml, in 5 mM TrisCl buffer, pH 7.4, 
containing 10 mM magnesium acetate and 86 mM 
KCl. Ribosome suspensions (1 ml) were incubated for 
5 min at 30’ with or without puromycin (0.1 mM). 
For translocation studies, ribosomes were sedimented 
from incorporation mixtures, were washed by two 
cycles of centrifugation in 5 mM TrisCl buffer, pH 
7.4, containing 10 mM magnesium acetate and 500 
1 
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mM NH,Cl, and were then resuspended in 5 mM Tris- 
Cl buffer, pH 7.4, containing 10 mM magnesium 
acetate and 86 mM KCl. Samples (1 ml) were incubated 
with puromycin in an additional reaction mixture 
(1 ml) as described under table 2. 
The release of nascent protein from puromycin- 
treated ribosomes was estimated [ 11 J . Results are 
expressed as percentage of nascent protein released 
from ribosomes, relative to 100% bound oncontrol 
ribosomes. 
“C-labelled Chlorella protein hydrolysate (52 
mCi/matom carbon) was.obtained from the Radio- 
chemical Centre @me&ram, England). Puromycin 
dihydrochloride was obtained from the Nutritional 
Biochemicals Corporation (Cleveland, Ohio). Chlor- 
tetracycline, erythromycin and thiostrepton were 
generously provided by Dr. Eric Cundliffe. 
3. Results and discussion 
Thiostrepton and erythromycin are potent in- 
hibitors of protein synthesis in E. coli both in vivo 
and in vitro. We have used chlortetracycline as a 
control inhibitor - it inhibits the codon-directed 
binding of amino acyl-tRNA to ribosomes [ 121. We 
can thus relate results obtained with an antibiotic of 
known mechanism of action to results obtained with 
an antibiotic of unknown action. 
We have determined if the three antibiotics used 
here inhibit the puromycin reaction with ribosome- 
bound nascent peptides formed under the influence 
of natural messenger RNA. The results are presented 
in table 1. Labelled ribosome suspensions were in- 
cubated with puromycin in the presence or absence 
of chlortetracycline, thiostrepton or erythromycin and 
the amounts of nascent protein released were deter- 
mined. The three inhibitors were present at very high 
concentration (250 /+qrjml) - a five-fold excess over 
the level of puromycin used (50 &/ml). These high 
concentrations were chosen deliberately to bias the 
experiment in favour of inhibition. Neither chlortetra- 
acycline nor thiostrepton inhibited the puromycin 
reaction. With erythromycin, the puromycin reaction 
was inhibited to a very small, but consistent, extent 
(10%). Washed ribosomes, as prepared for this experi- 
ment, have peptidyl-tRNA bound to either site A or 
site P of the ribosome. As seen from table 1, puro- 
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Table 1 
Antibiotic effects on the puromycin reaction with washed 
ribosomes. 
System 
Protein 
released 
from ribo- 
somes by 
puromycin 
(%) 
Inhibition 
of the 
puromycin 
reaction 
f%) 
Control ribosomes 35 - 
Ribosomes + chlortetracycline 34.5 - 
Ribosomes + thiostrepton 35.5 - 
Ribosomes + erythromycin 31.5 10 
Labelled ribosome suspensions (specific activity 15,000 dpm/ 
mg) were prepared as described in sect. 2. Samples (1 ml) 
were incubated for 5 mm at 30” with puromycin (0.1 mM). 
Release of nascent protein was determined as described in 
sect. 2. The effects, on the reaction, of chlortetracycline, 
thiostrepton and erythromycin at concentrations of 250 
&ml, were determined. 
mycin releases 35% of the bound nascent peptides. 
Since the reaction needs only the correct ionic environ- 
ment, only those ribosomes with peptidyl-tRNA 
bound at site P react with puromycin. Any inhibition 
of the reaction under these conditions represents an 
inhibition of peptidyl transferase - an inhibition 
characteristic of several antibiotics [ 11, 131. Clearly, 
however, peptidyl transferase is not inhibited directly 
by either chlortetracycline or thiostrepton under our 
conditions. Since chlortetracycline acts on the 30 S 
ribosomal subunit, it should not inhibit the puromycin 
reaction which is a property of the 50 S subunit. Our 
results support this interpretation and agree with 
those of others [9] . 
Erythromycin is particularly interesting. It inhibits 
peptidyl transferase to only a very small extent, and 
this inhibition could be artefactual. Under certain con- 
ditions, in vivo, erythromycin does not significantly 
inhibit the puromycin reaction [9] and other workers 
[ 131 have claimed that, in vitro, peptidyl transferase 
is not inhibited by erythromycin. However, Tanaka 
et al. [ 141 have postulated that erythromycin selec- 
tively inhibits the puromycin reaction with ribosome- 
bound phenylalanyl-phenylalanyl-tRNA. This situa- 
tion will be discussed later in this paper. 
We have tested the three antibiotics for their ability 
to inhibit translocation. Labelled ribosomes, sedimented 
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Table 2 Table 3 
Antibiotic effects on the puromycin reaction with NH&l- 
washed ribosomes in the presence of GTP and supernatant 
fraction. 
Inhibition of rtbosomes in the puromycin reaction by pre- 
treatment of crude extracts with antibiotics during protein 
synthesis. 
Protein Protein 
released released 
System 
from ribo- 
somes by 
puromycin 
(%) 
(1) Control ribosomes 
(2) Ribosomes + reaction mixture 
minus supematant fraction 
36 
35 
(3) Ribosomes + reaction mixture 65 
As for (3) + chlortetracycline 66 
As for (3) + thiostrepton 40 
As for (3) + erythromycin 60 
Ribosomes were washed with NH&l as described in sect. 2. 
1 ml samples (specific activity 13,000 dpm/mg) were incub- 
ated for 5 min at 30” with puromycin (0.1 mM) in the pres- 
ence of a reaction mixture (1 ml) containing 5 pmole phos- 
phoenolpyruvate, 1 pmole ATP, 0.15 pmole GTP, 50 Irg 
pyruvate kinase, 6 pmole mercaptoethanol and 0.2 ml super- 
natant fraction in 5 mM Tris-Cl buffer, pH 7.4, containing 10 
mM magnesium acetate and 86 mM KCl. As under table 1 
chlortetracycline, thiostrepton or erythromycin were added, 
and the effects on the release of protein studied. 
from an incorporation mixture, were washed with a 
buffer containing NH,Cl as described in sect. 2. This 
treatment removes any bound G factor. Puromycin 
reacts with ribosomes, washed in this way, to release 
peptides from peptidyl-tRNA bound at site P. For 
translocation to occur, these ribosomes need added G 
factor and GTP. Theformer is present in ribosome-free 
supernatant fractions. Ribosomes prepared as above 
were incubated with GTP, supernatant fraction and 
puromycin, in the absence or presence of the three 
antibiotics. Nascent protein release was estimated and 
the results are shown in table 2. Addition of GTP and 
supernatant fraction to control ribosomes almost 
doubles the stripping action of puromycin by effecting 
translocation of peptidyl-tRNA from site A to site 
P. The maximal stripping obtained (approximately 
70%) is characteristic of the puromycin reaction under 
these conditions. Although in theory 100% stripping 
should be observed this level is never reached for 
reasons which have never been satisfactorily explained. 
System 
from ribo- 
somes by 
puromycin 
(%) 
Control ribosomes 
Ribosomes from extracts treated 
with chlortetracycline 
Ribosomes from extracts treated 
with thiostrepton 
Ribosomes from extracts treated 
with erythromycin 
36 
55 
57 
14 
Incorporation mixtures were incubated for 5 min at 30”. One 
control sample (1.5 ml) was chilled on ice and to three other 
samples (1.5 ml) was added 500 fig of chlortetracycline, 
thiostrepton or erythromycin. Incubation was continued for 
5 mm before chilling. The samples were diluted with ice-cold 
5 mM TrisCl buffer, pH 7.4, containing 10 mM magnesium 
acetate and the ribosomes were sedimented by centrifugation 
at 165,000 g for 45 min. The pellets were resuspended, in 
5 mM TrisCl buffer, pH 7.4, containing 10 mM magnesium 
acetate and 86 mM KCl, to a concentration of 2 mg/ml and 
assayed in the puromycin reaction as for table 1. Specific 
activity of ribosomes was 15,000 dpm/mg. 
Table 2 shows that chlortetracycline has no effect on 
the puromycin reaction in the presence of GTP, and 
as discussed earlier this result is expected. Erytho- 
mycin exerts a small inhibitory effect on the puro- 
mycin reaction under these conditions. This is con- 
sistent with the results illustrated in table 1 and pre- 
sumably represents a small inhibition of peptidyl 
transferase. Thiostrepton inhibits the puromycin 
reaction in the presence of GTP and G factor very 
markedly. Since thiostrepton does not inhibit the 
puromycin reaction directly (table 1) it seems that 
the antibiotic inhibits translocation under the above 
conditions. Although this interpretation agrees with 
the conclusions of others [8] , it is at variance with 
recent work by Cundliffe [ 151. 
We have used the three antibiotics to inhibit 
E. coli cell-free extracts which are actively synthesis- 
ing protein, to attempt to block peptidyl-tRNA in 
3 
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either site A or site P. Incorporation mixtures were 
prepared and incubated. After 5 min a control incor- 
poration was chilled and to three others chlortetra- 
cycline, thiostrepton or erythromycin were added. In- 
cubations were continued for 5 min before chilling. 
The samples were diluted and the ribosomes sedi- 
mented, resuspended and assayed in the puromycin 
reaction with no added GTP. The results are shown in 
table 3. Control ribosomes release the expected amount 
of nascent protein. Ribosomes from extracts inhibited 
with either chlortetracycline or thiostrepton behave 
similarly in the puromycin reaction, and amounts of 
nascent protein released were markedly higher than 
for control ribosomes, approaching the levels normally 
released by puromycin in the presence of GTP and 
supernatant fraction (cf. table 2). With ribosomes from 
extracts inhibited with erythromycin the reverse was 
true. The amount of nascent protein released was 
markedly less than from control ribosomes. 
This result with erythromycin in unexpected. It 
failed to inhibit translocation under our conditions 
and was a poor inhibitor of the puromycin reaction 
itself. However, if the antibiotic is added to a system 
synthesising protein the ribosomes accumulate pep 
tidyl-tRNA in a state where it is unable to react with 
puromycin (table 3). This effect would be expected 
of a translocation inhibitor which would allow peptide 
transfer but would restrict peptidyl-tRNA to site A, 
where it would be unable to react with puromycin. 
This result agrees with that of Cundliffe and McQuillen 
[9] who concluded that erythromycin inhibited trans- 
location. Furthermore, the antibiotic inhibits the 
release of deacylated-tRNA, from ribosomes, which 
normally occurs during translocation [ 161 . Possibly, 
erythromycin can inhibit translocation only when 
added to ribosomes actively engaged in protein syn- 
thesis (table 3). Addition to a fractionatc rl and more 
artificial system (table 2) may not favour inhibition. 
With washed ribosomes with G factor and excess GTP 
a translocation inhibitor would have to act extremely 
efficiently since a single translocation event would 
cancel any inhibitory effect. 
There is a further possibility. If chloramphenicol 
is used in the experiment of table 3 an identical result 
to the one using erythromycin is obtained [ 1 l] . 
Chloramphenicol does not inhibit translocation but 
binds to peptidyl transferase and greatly inhibits this 
enzyme in the puromycin reaction. This reaction with 
4 
washed ribosomes (conditions of table 1) is also in- 
hibited by chloramphenicol, but to a smaller extent 
(cf. erythromycin). Since erythromycin and chloram- 
phenicol compete for binding sites on the 50 S sub- 
unit [ 171 possibly the two antibiotics act similarly. 
Erythromycin may inhibit peptidyl transferase by 
binding to a I IsiLve site on the enzyme only under 
conditions of pLotein synthesis. This could explain 
why erythromycin is a poor inhibitor of the puromycin 
reaction with washed ribosomes (table 1). Alternative- 
ly, erythromycin may only inhibit the enzyme efficient- 
ly when polypeptide chains of certain amino acid 
composition and chain length are bound on the ribo- 
somes. Washed ribosomes carrying a heterogeneous 
population of protein chains may be poorly inhibited 
(table 1). Conversely, blockage of peptidyl transfer 
during protein synthesis (table 3) may select condi- 
tions for maximal inhibition by the antibiotic. This 
interpretation is based upon recent work by Tanaka 
et al. [14]. 
In table 3 the result obtained with chlortetra- 
cycline is expected. The antibiotic prevents binding of 
amino acyl-tRNA to site A but inhibits neither the 
puromycin reaction with washed ribosomes nor trans- 
location studied under our conditions. Ribosomes in- 
hibited during protein synthesis by cblortetracycline 
should accumulate peptidyl-tRNA in site P since 
normal peptidyl transfer is prevented. 
The result with thiostrepton is surprising. Under 
certain conditions thiostrepton inhibits translocation. 
Ribosomes inhibited during protein synthesis by 
thiostrepton should, therefore, accumulate peptidyl- 
tRNA in site A. In our experiments this is clearly not 
the case although again this result agrees with recent 
work by Cundliffe [ 151 
The similar behaviour of thiostrepton and chlor- 
tetracycline (table 3) is significant. Modolell (personal 
communication) claims that thiostrepton blocks 
binding of alanyl-tRNA to site A of ribosomes, under 
certain conditions. Our results, and those of Cundliffe 
[ 151, could indicate that inhibition of amino acyl- 
tRNA binding to ribosomes is the primary site of 
action of thiostrepton during inhibition of protein 
synthesis both in viva and in vitro. As with chlortetra- 
cycline this inhibition blocks peptidyl-tRNA at site P. 
As an inhibitor of protein synthesis thiostrepton may 
never need to inhibit translocation, although undoubtedly 
such an inhibition can occur under selected artificial 
conditions in vitro. 
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